Active Pharmaceutical Ingredient

Rivastigmine — CAS 128298-28-2

Also known as: ENA 713; SDZ ENA 713

GMP Certified IP / BP / EP / USP Cholinesterase Inhibitor / Alzheimer's Agent Aurangabad, India
Rivastigmine API Supplier Manufacturer Aurangabad Maharashtra India — Mediocon Inc
Rivastigmine IP / BP / EP / USP  |  GMP Certified  |  Mediocon Inc, Maharashtra, India
CAS No: 128298-28-2

Product Overview

Rivastigmine is a high-purity Active Pharmaceutical Ingredient (API) classified under Cholinesterase Inhibitor / Alzheimer's Agent. Mediocon Inc manufactures GMP-compliant Rivastigmine at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation.

Therapeutic Applications
  • Alzheimer's disease treatment
  • Dementia associated with Parkinson's disease
  • Cholinesterase inhibition therapy
  • Mild to moderate dementia management

Technical Specifications

ParameterSpecification
CAS Number128298-28-2
Molecular FormulaC₁₄H₂₂N₂O₂
Molecular Weight250.34 g/mol
GradeIP / BP / EP / USP
CategoryCholinesterase Inhibitor / Alzheimer's Agent
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Batch NoRIV/24032026
Mfg DateMAR 2026
Exp DateFEB 2031
Packing25 kg HDPE drums / as per requirement

Quality & Compliance

  • GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
  • Full pharmacopoeial compliance: IP / BP / EP / USP standards
  • Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
  • Stringent in-process quality control at every manufacturing stage
  • HPLC purity testing and spectroscopic identification (IR, NMR)
  • Cold-chain and controlled-environment storage facilities available
  • Exported to 40+ countries with full regulatory support
💬
Mediocon AI
Hello 👋 How can I help you today?